Obstetric Disorders in the ICU

Clinics in Chest Medicine

Volumn 30, Issue 1, 2009, Pages 89-102

  Bourjeily, Ghada ^a   Miller, Margaret ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Acute fatty liver of pregnancy; Amniotic fluid embolism; Eclampsia; HELLP; Ovarian hyperstimulation syndrome; Pre eclampsia; Pulmonary edema; Venous thromboembolism

Indexed keywords

ATOSIBAN; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; DOPAMINE; FUROSEMIDE; GLUCOCORTICOID; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; INDOMETACIN; LABETALOL; LOOP DIURETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MAGNESIUM SULFATE; NIFEDIPINE; NITROPRUSSIDE SODIUM; OXYTOCIN; PHENYTOIN; RITODRINE; STREPTOKINASE; TERBUTALINE; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; UROKINASE; UTERUS SPASMOLYTIC AGENT; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; WARFARIN;

AMNION FLUID EMBOLISM; ANTICOAGULATION; ARTIFICIAL VENTILATION; BLEEDING; BRAIN ISCHEMIA; BRAIN VASOSPASM; CARDIOMYOPATHY; CLINICAL TRIAL; COMPRESSION GARMENT; CONGESTIVE HEART FAILURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ECLAMPSIA; FATTY LIVER; FLUID THERAPY; GROUPS BY AGE; HELLP SYNDROME; HUMAN; HYPERTENSION ENCEPHALOPATHY; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG EDEMA; LUNG EMBOLISM; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MEDICAL CARE; OBSTETRIC CARE; OLIGURIA; OVARY HYPERSTIMULATION; PREDICTOR VARIABLE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RADIODIAGNOSIS; RESPIRATORY ARREST; REVIEW; RISK FACTOR; SEIZURE; SODIUM RESTRICTION; TERATOGENICITY; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; INTENSIVE CARE UNITS; MATERNAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; RISK ASSESSMENT;

EID: 58849118119     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.10.004     Document Type: Review

References (101)

1. Rizk N.W., Kalassian K.G., Gilligan T., et al. Obstetric complications in pulmonary and critical care medicine. Chest 110 (1996) 791-809
2. Karnad D.R., Lapsia V., Krishman A., et al. Prognostic factors in obstetric patients admitted to an Indian intensive care unit. Crit Care Med 32 (2004) 1294-1299
3. Kaaja R.J., and Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 294 21 (2005) 2751-2757
4. Panchal S., Arria A.M., and Harris A.P. Intensive care utilization during hospital admission for delivery. Anesthesiology 92 (2000) 1527-1544
5. Rochat R.W., Koonin L.M., Atrash H.K., et al. The Maternal Mortality Collaborative 2 Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol 72 1 (1988) 91-97
6. In: Lewis G. (Ed). The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer-2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom (2007), CEMACH, London
7. Tuffnell D.J., Jankowicz D., Lindow S.W., et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 112 (2005) 875-880
8. Meekins J.W., Pijnenborg R., Hanssens M., et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. BJOG 101 8 (1994) 669-674
9. Magee L.A., Helewa M., Moutquin J.M., et al. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 30 3 Suppl 1 (2008) 1-48
10. Which anticonvulsant for women with ecclampsia? Evidence from the collaborative ecclampsia trial. Lancet 345 (1995) 1455
11. Sibai B.M., Mabie B.C., Harvey C.J., et al. Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am J Obstet Gynecol 156 5 (1987) 1174-1179
12. Rackow E.C., Fein A.I., and Lippo J. Colloid osmotic pressure as a prognostic indicator of pulmonary edema and mortality in the critically ill. Chest 79 (1977) 709
13. Oian P., and Maltau J.M. Transcapillary forces in normal pregnant women. Acta Med Scand Suppl 693 (1985) 19-22
14. Benedetti T.J., Starzyk P., and Frost F. Maternal deaths in Washington State. Obstet Gynecol 66 1 (1985) 99-101
15. Barton J.R., and Sibai B.M. Life-threatening emergencies in PEC-eclampsia. J Ky Med Assoc 104 9 (2006) 410-418
16. Yeast J.D., Halberstadt C., Meyer B.A., et al. The risk of pulmonary edema and colloid osmotic pressure changes during magnesium sulfate infusion. Am J Obstet Gynecol 169 (1993) 1566-1571
17. Easterling T.R., Benedetti T.J., Schmucker B.C., et al. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 76 6 (1990) 1061-1069
18. Bosio P.M., McKenna P.J., Conroy R., et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 94 6 (1999) 978-984
19. Hjertberg R., Belfrage P., and Hagnevik K. Hemodynamic measurements with Swan-Ganz catheter in women with severe proteinuric gestational hypertension (pre-eclampsia). Acta Obstet Gynecol Scand 70 3 (1991) 193-198
20. Penny J.A., Anthony J., Shennan A.H., et al. A comparison of hemodynamic data derived by pulmonary artery flotation catheter and the esophageal Doppler monitor in PEC. Am J Obstet Gynecol 183 3 (2000) 658-661
21. Gilbert W.M., Towner D.R., Field N.T., et al. The safety and utility of pulmonary artery catheterization in severe PEC and eclampsia. Am J Obstet Gynecol 182 (2000) 1397-1403
22. Rang S., van Montfrans G.A., and Wolf H. Serila hemodynamic measurement in normal pregnancy, PEC and fetal growth restriction. Am J Obstet Gynecol 198 5 (2008) 519e1-9
23. Magee L.A., Cahm C., Waterman E.J., et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 327 (2003) 955-960
24. Duley L., Henderson-Smart D.J., and Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 3 (2006 Jul 19) CD001449
25. Magee L.A., Miremadi S., Li J., et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with PEC. Am J Obstet Gynecol 193 (2005) 153-163
26. Sibai B.M., Ramadan M.K., Usta I., et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169 4 (1993) 1000-1006
27. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 5 Pt 1 (2004) 981-991
28. Matchaba P., and Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 1 (2004) CD002076
29. Fonseca J.E., Mendez F., Catano C., et al. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193 5 (2005) 1591-1598
30. Riely C.A. Acute fatty liver of pregnancy. Semin Liver Dis 7 (1987) 47
31. King J.F., Grant A., Keirse M.J., et al. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 95 3 (1988) 211-222
32. Perry Jr. K.G., Morrison J.C., Rust O.A., et al. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 173 4 (1995) 1273-1277
33. Gabriel R., Harika G., Saniez D., et al. Prolonged intravenous ritodrine therapy: a comparison between multiple and singleton pregnancies. Eur J Obstet Gynecol Reprod Biol 57 (1994) 65-71
34. Bax A., Middeldorp A.M., Harinck B., et al. Unilateral pulmonary edema as a life-threatening complication of ritodrine. Acta Obstet Gynecol Scand 78 10 (1999) 915-916
35. Sciscione A.C., Ivester T., Largoza M., et al. Acute pulmonary edema in pregnancy. Obstet Gynecol 101 3 (2003) 511-515
36. Nassar A.H., Ghazeeri G., and Usta I.M. Nifedipine-associated pulmonary complications in pregnancy. Int J Gynaecol Obstet 97 2 (2007) 148-149
37. Carbonne B., Papatsonis D.N., Flenady V.J., et al. Comment on the article "Acute pulmonary oedema during nicardipine therapy for premature labour. Report of five cases" by Vaast P, et al. Eur J Obstet Gynecol Reprod Biol 120 1 (2005) 119 [author reply 119-20]
38. Samol J.M., and Lambers D.S. Magnesium sulfate tocolysis and pulmonary edema: the drug or the vehicle?. Am J Obstet Gynecol 192 5 (2005) 1430-1432
39. Steiner P.E., and Lushbaugh C.C. Landmark article, Oct. 1941: maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. By Paul Steiner and C.C. Lushbaugh. JAMA 255 16 (1986) 2187-2203
40. Clark S.L., Hankins G.D., Dudley D.A., et al. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 172 4 Pt 1 (1995) 1158-1167
41. Tuffnell D.J., and Johnson H. Amniotic fluid embolism: the UK register. Hosp Med 61 8 (2000) 532-534
42. Tuffnell D.J. Amniotic fluid embolism. Curr Opin Obstet Gynecol 15 (2003) 119-122
43. Gilbert W.M., and Danielsen B. Amniotic fluid embolism: decreased mortality in a population based study. Obstet Gynecol 93 (1999) 973-977
44. Clark S.L., Pavlova Z., Greenspoon J., et al. Squamous cells in the maternal circulation. Am J Obstet Gynecol 154 (1986) 104-106
45. Aurangzeb I., George L., and Roof S. Amniotic fluid embolism. Crit Care Clin 20 (2004) 643-650
46. Shechtman M., Ziser A., Markovits R., et al. Amniotic fluid embolism: findings on transesophageal echocardiography. Anesth Analg 89 (1999) 1456
47. Stanten R.D., Iverson L.I., Daugharty T.M., et al. Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: diagnosis by transesophageal echocardiogram and treatment by cardiopulmonary bypass. Obstet Gynecol 102 (2003) 496
48. Hankins G.D., Snyder R.R., Clark S.L., et al. Acute hemodynamic and respiratory effects of amniotic fluid embolism in the pregnant goat model. Am J Obstet Gynecol 168 4 (1993) 1113-1129
49. Dib N., and Bajwa T. Amniotic fluid embolism causing severe left ventricular dysfunction and death: case report and review of the literature. Cathet Cardiovasc Diagn 39 (1996) 177-180
50. Fletcher S.J., and Parr M. Amniotic fluid embolism: a case report and review. Resuscitation 43 (2000) 141-146
51. Clark S.L., Cotton D.B., Gonik B., et al. Central hemodynamic alterations in amniotic fluid embolism. Am J Obstet Gynecol 158 (1988) 1124-1126
52. Girard P., Mal H., Laine J.F., et al. Left heart failure in amniotic fluid embolism. Anesthesiology 64 (1986) 262-265
53. Moore J., and Baldisseri M.R. Amniotic fluid embolism. Crit Care Med 33 10 (2005) S279-S285
54. Oi H., Kobayashi H., Hirashima Y., et al. Serological and immunohistochemical diagnosis of amniotic fluid embolism. Semin Thromb Hemost 24 5 (1998) 479-484
55. Kobayashi H., Oi H., Hayakawa H., et al. Histological diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc epitope. Hum Pathol 28 4 (1997) 428-433
56. The practice committee of the American Society of Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 82 Suppl 1 (2004) S81-S86
57. Wang T.H., Horng S.G., Chang C.L., et al. Human chorionic gonadotropin -induced ovarian hyperstimulation syndrome: two distinct entities with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab 87 (2002) 3300-3308
58. Binder H., Dittrich R., Einhaus F., et al. Update on ovarian hyperstimulation syndrome: part I-incidence and pathogenesis. Int J Fertil 52 1 (2007) 11-26
59. Agrawal R., Conway G., Sladkevicius P., et al. Serum vascular endothelial growth factor and Doppler blood flow velocities In in-vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 70 (1998) 651-658
60. Levin E.R., Rosen F.G., Cassidenti D.L., et al. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 102 (1998) 1978-1985
61. Practice committee for the American Society of Reproductive Medicine. Ovarian Hyperstimulation syndrome. Fertil Steril 86 5 Suppl 1 (2006) S178-S183
62. Biron C., Galtier-Dereure F., Rabesandratana H., et al. Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study. Fertil Steril 67 1 (1997) 104-109
63. Ferraretti A.P., Gianaroli L., Diotallevi L., et al. Dopamine treatment for severe ovarian hyperstimulation syndrome. Humanit Rep 7 2 (1992) 180-183
64. Vlahos N.F., and Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann N Y Acad Sci 1092 (2006) 247-264
65. Biaggi A., Paradisi G., Ferrazzani S., et al. Maternal mortality in Italy, 1980-1996. Eur J Obstet Gynecol Reprod Biol 114 (2004) 144-149
66. Samuelsson E., Hellgren M., and Hogberg U. Pregnancy related deaths due to pulmonary embolism in Sweden. Acta Obstet Gynecol 86 (2007) 435-443
67. Panting-Kemp A., Geller S.E., Ngyen T., et al. Maternal deaths in an urban perinatal network, 1992-1998. Am J Obstet Gynecol 183 5 (2000) 207-1212
68. Sullivan E.A., Ford J.B., Chambers G., et al. Maternal mortality in Australia, 1973-1996. Aust N Z J Obstet Gynaecol 44 (2004) 452-457
69. Andersen B.S., Steffensen F.H., Sorensen H.T., et al. The cumulative incidence of venous thromboembolism during pregnancy and puerperium. An 11 year Danish population - based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 77 (1998) 170-173
70. Gherman R.B., Goodwin T.M., Leung B., et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 94 (1999) 730-734
71. Simpson E.L., Lawrenson R.A., Nightingale A.L., et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG 108 (2001) 56-60
72. Clark P., Brennand J., Conkie J.A., et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 79 (1998) 1166-1170
73. Macklon N.S., Greer I.A., and Bowman A.W. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 104 (1997) 191-197
74. Blanco-Molina, Trujillo-Santos J., Criado J., et al. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE registry. Thromb Haemost 97 2 (2007) 186-190
75. Macklon N.S., and Greer I.A. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 41 (1996) 83-86
76. McColl M.D., Ramsay J.E., Tait R.C., et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 78 (1997) 1183-1188
77. Danilenko-Dixon D.R., Heit J.A., Silverstein M.D., et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 184 (2001) 104-110
78. Wicki J., Perneger T.V., Junod A.F., et al. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 161 1 (2001) 92-97
79. Wells P.S., Anderson D.R., Rodger M.A., et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 135 (2001) 98-107
80. Wells P.S., Anderson D.R., Rodger M.A., et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 83 (2000) 416-420
81. Perrier A., Desmarais S., Miron M.J., et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 353 (1999) 190-195
82. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263 (1990) 2753-2759
83. Powrie R.O., Larson L., Rosene-Montella K., et al. Alveolar-arterial oxygen gradient in acute pulmonary embolism in pregnancy. Am J Obstet Gynecol 178 2 (1998) 394-396
84. Chan W.S., Ray J.G., Murray S., et al. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 162 10 (2002) 1170-1175
85. Balan K.K., Critchley M., Vedavathy K.K., et al. The value of ventilation-perfusion imaging in pregnancy. Br J Radiol 70 832 (1997) 338-340
86. Yoo D, Lazarus E, Khalil H, et al. Diagnostic yield of ventilation perfusion (V/Q) scans in pregnancy: review of the findings in 315 consecutive pregnant patients from 1999 through 2006. Presented at RSNA meeting, Chicago, IL, November 25-30, 2007.
87. Winer-Muram H.T., Boone J.M., Brown H.L., et al. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology 224 2 (2002) 487-492
88. Hopper K.D., King S.H., Lobell M.E., et al. The breast: in-plane x-ray protection during diagnostic thoracic CT-shielding with bismuth radioprotective garments. Radiology 205 3 (1997) 853-858
89. Parker M.S., Hui F.K., Camacho M.A., et al. Female breast radiation exposure during CT pulmonary angiography. AJR Am J Roentgenol 185 (2005) 1228-1233
90. Khalil H, Bourjeily G, Lazarus E, et al. Multidetector CT pulmonary angiograms in pregnant patients: the "limited, no central PE"-how limited? Presented at RSNA meeting, Chicago, IL, November 25-30, 2007.
91. Bourjeily G., Khalil H., Habr F., et al. Multidetector-row computed tomography in the detection of pulmonary embolism in pregnancy. Chest 132 4 (2007) 500S
92. Webb J.A., Thomsen H.S., and Morcos S.K. Members of the contrast media safety committee of the european society of urogenital radiology. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15 (2005) 1234-1240
93. Atwell T.D., Lteif A.N., Brown D.L., et al. Neonatal thyroid function after administration of IV iodinated contrast agents to 21 pregnancy patients. AJR 191 (2008) 268-271
94. Torres J.A., Aracil E., Puras E., et al. Role of venous duplex imaging of lower extremity for pulmonary embolism diagnosis. Angiologia 51 (1999) 71-76
95. MacGillavry M., Sanson B., Buller H., et al. Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful?. Thromb Haemost 884 (2000) 973-976
96. Turkstra F., Kuijer P.M., van Beek E.J., et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 126 10 (1997) 775-781
97. Barrelier M., Lezin B., Landy S., et al. Prevalence of duplex ultrasonography detectable venous thrombosis in patients with suspected or acute pulmonary embolism. J Mal Vasc 26 (2001) 23-30
98. Pettila V., Leinonen P., Markkola A., et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 87 (2002) 182-186
99. Turrentine M.A., Braems G., and Ramirez M.M. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 50 (1995) 534-541
100. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 9 (2000) 1183-1188
101. Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24 (2003) 761-781